Lipocalin 2 Influences Bone and Muscle Phenotype in the
Duchenne Muscular Dystrophy
Lipocalin 2
bone
inflammation
muscle
osteoporosis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
16 Jan 2022
16 Jan 2022
Historique:
received:
30
11
2021
revised:
13
01
2022
accepted:
14
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
9
2
2022
Statut:
epublish
Résumé
Lipocalin 2 (Lcn2) is an adipokine involved in bone and energy metabolism. Its serum levels correlate with bone mechanical unloading and inflammation, two conditions representing hallmarks of Duchenne Muscular Dystrophy (DMD). Therefore, we investigated the role of Lcn2 in bone loss induced by muscle failure in the
Identifiants
pubmed: 35055145
pii: ijms23020958
doi: 10.3390/ijms23020958
pmc: PMC8780970
pii:
doi:
Substances chimiques
Lipocalin-2
0
Lcn2 protein, mouse
126469-30-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : French Muscular Dystrophy Association
ID : #20006
Références
J Am Heart Assoc. 2017 Jun 14;6(6):
pubmed: 28615213
Biomarkers. 2015;20(8):565-71
pubmed: 26671823
J Bone Miner Res. 2011 Aug;26(8):1891-903
pubmed: 21509823
J Biol Chem. 2012 Feb 10;287(7):4808-17
pubmed: 22117066
Sci Transl Med. 2015 Aug 5;7(299):299rv4
pubmed: 26246170
J Am Soc Nephrol. 2003 Oct;14(10):2534-43
pubmed: 14514731
J Cell Physiol. 2017 Aug;232(8):2125-2134
pubmed: 27800610
Trends Endocrinol Metab. 2017 May;28(5):388-397
pubmed: 28214071
Annu Rev Nutr. 2017 Aug 21;37:103-130
pubmed: 28628361
PLoS One. 2015 Jan 21;10(1):e0117306
pubmed: 25607927
Nature. 2017 Mar 16;543(7645):385-390
pubmed: 28273060
J Bone Miner Res. 2018 Jun;33(6):1141-1153
pubmed: 29444358
Lancet Neurol. 2018 Mar;17(3):251-267
pubmed: 29395989
Joint Bone Spine. 2011 Dec;78(6):572-6
pubmed: 21664854
PLoS One. 2019 Apr 22;14(4):e0215590
pubmed: 31009514
Hum Mol Genet. 2008 Dec 15;17(24):3909-18
pubmed: 18784278
Scand J Immunol. 2015 Jan;81(1):31-8
pubmed: 25359467
J Med Invest. 2001 Aug;48(3-4):147-56
pubmed: 11694954
Int J Endocrinol. 2015;2015:928385
pubmed: 26124831
J Bone Miner Res. 2013 Jan;28(1):2-17
pubmed: 23197339
Mediators Inflamm. 2013;2013:540370
pubmed: 24302815
Osteoarthritis Cartilage. 2017 Jul;25(7):1172-1178
pubmed: 28185846
Immun Ageing. 2005 Nov 04;2:14
pubmed: 16271143
Osteoporos Int. 2003 Sep;14(9):761-7
pubmed: 12897980
Am J Physiol Cell Physiol. 2018 Nov 1;315(5):C714-C721
pubmed: 30257107
J Bone Miner Res. 2015 Feb;30(2):357-68
pubmed: 25112732
Hum Genet. 1984;66(1):17-40
pubmed: 6365739
Lancet Neurol. 2018 Apr;17(4):347-361
pubmed: 29395990
Biochim Biophys Acta. 2000 Oct 18;1482(1-2):284-97
pubmed: 11058769
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1834-9
pubmed: 16446425
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Front Physiol. 2017 May 05;8:279
pubmed: 28529490
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3710-4
pubmed: 8475120
J Cell Physiol. 2021 Jul 5;:
pubmed: 34224151
EBioMedicine. 2015 Feb 26;2(4):285-93
pubmed: 26137572
J Cell Physiol. 2013 Nov;228(11):2210-21
pubmed: 23606520
J Cell Biochem. 2009 May 15;107(2):240-52
pubmed: 19288527
Circ J. 2010 Mar;74(3):523-30
pubmed: 20057160